Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Tamer Mölnlycke Care celebrates a new chapter in healthcare in the Kingdom of Saudi Arabia
Gothenburg, Sweden. 26 February 2025. Tamer Mölnlycke Care has officially been inaugurated by the Minister of Health for the Kingdom of Saudi Arabia, Fahad Al-Jalajel, at the Deputy Governor of Makkah Region Prince Saud bin Mishal bin Abdulaziz Emirate. This marks a major milestone in the joint venture between Mölnlycke Health Care, a world-leading MedTech company and the Tamer Group, market leader in healthcare distribution in Saudi Arabia.
Tamer Mölnlycke Care, based in Jeddah, Saudi Arabia will manufacture and distribute Mölnlycke products and innovative solutions to meet customer demand both within the country and the surrounding region. These offerings include customised surgical procedure trays, surgical drapes and gowns, an emollient range and selected wound care products. Manufacturing of the customised procedure trays has commenced last month, with other products being introduced throughout 2025.
Zlatko Rihter, CEO of Mölnlycke comments “This partnership underscores our dedication to the Middle Eastern market and aligns with the Saudi Vision 2030. By expanding our product range and investing locally, we aim to enhance healthcare quality and contribute to regional growth. We extend our gratitude to Tamer Group for their unwavering support and look forward to achieving great milestones together.”
Mahmoud Wagih, CEO, Tamer Mölnlycke Care comments “This is a momentous day for the team at Tamer Mölnlycke Care who have worked tirelessly to prepare us for business. This joint venture between two well established businesses is not only exciting for regional investment but also crucial in providing healthcare professionals and patients with access to high-quality products and solutions that will improve outcomes.”
The Tamer Mölnlycke Care joint venture is a long-term agreement between two organisations who have been working in partnership over the past decade; and are committed to meeting customer demand in the evolving healthcare landscape of Saudi Arabia and the wider region and contributing to the broader goals of Saudi Arabia's Vision 2030.
For more information, please contact:
About Tamer
Established in 1922 by the late Dr. Mohammed Said Tamer, Tamer Group started as the first pharmacy in the Arabian Peninsula. Today, it is a leading business that stands as a trusted partner of choice for world’s leading partners in the healthcare, beauty and wellness, logistics, e-commerce and fast-moving consumer goods catering to the escalating needs of the Saudi and Middle Eastern communities. The group specialises in importation, distribution, and manufacturing. www.TamerGroup.com
About Tamer Mölnlycke Care
Tamer Mölnlycke Care is a strategic joint venture between Mölnlycke Health Care and Tamer Group, headquartered in Saudi Arabia. The venture focuses on manufacturing high-quality operating room solutions to improve efficiency and reduce waste across healthcare providers in the GCC and MENA regions. With Mölnlycke’s increased ownership stake to 60%, the joint venture is set to expand its local production to include advanced wound care solutions, drapes, gowns, and emollients, with factory operations launching in 2025.
Latest news
-
Mölnlycke advocates a holistic approach to healthcare sustainability
New white paper calls for integration of environmental, human and economic metrics in sustainability assessments of medical technologies.
-
Mölnlycke Health Care unveils new headquarters at GoCo Health Innovation City, marking a new era of collaboration and innovation
-
Filippa Stenberg joins Mölnlycke Board of Directors
-
Mölnlycke Health Care inaugurates new global headquarters at GoCo Health Innovation City
Gothenburg, Sweden. 21 May 2025 – Mölnlycke Health Care, a global leader in MedTech, has officially opened its new global headquarters at GoCo Health Innovation City in Gothenburg, Sweden—a major milestone in its journey to drive sustainable healthcare innovation.
-
Mölnlycke Health Care’s long-term target to reach net zero emissions validated by Science Based Targets initiative
Gothenburg, Sweden. 13 May, 2025. Mölnlycke’s long-term net zero greenhouse gas (GHG) emission reduction targets have been validated by the Science Based Targets initiative (SBTi), following prior validation of the company’s near-term GHG emission reduction targets.
-
Mölnlycke Health Care supports the Wound Care Collaborative Community initiative to improve wound dressing standards
Gothenburg, Sweden. May 02, 2025. The Wound Care Collaborative Community (WCCC) is leading a groundbreaking initiative looking to develop a standardised pre-clinical testing framework for wound dressings.
-
Mölnlycke Health Care publishes Annual report for 2024
Gothenburg, Sweden. 1 April 2025. Today Mölnlycke Health Care has published its Annual report for 2024, including the sustainability report.
-
New study demonstrates the potential benefits of dressing regime improvements in delivering value-based chronic wound care
-
Mölnlycke Health Care announces launch of the 2025 Future Summit
Mölnlycke Health Care’s Wound Care business area is delighted to announce the launch of its 2025 Future Summit, an educational event bringing together healthcare professionals (HCPs) from across Europe, the Middle East, and Africa (EMEA).